Engineering the medicines
of tomorrow

You are here

The future of healthcare will be built on truly differentiated drugs, biopharmaceuticals that help to improve patients’ lives tomorrow and can really make a difference in areas of unmet medical need. At MorphoSys, all disciplines and teams work hand in hand to facilitate the advancement of new compounds, from their discovery through to clinical development.

We believe that successful drug development is not a matter of chance, but based on a profound understanding of disease biology, excellent technologies and extensive experience in the selection, characterization and development of therapeutic candidates. 

MorphoSys’s technologies and the expertise of its employees in the development of biologics support the search for drug candidates with unique properties.


With our skills and knowledge we have built a comprehensive portfolio of promising drug candidates. Our successful research alliances and proprietary development activities have led to more than 20 therapeutic antibodies in clinical trials to date. Going forward, we will concentrate even more on proprietary product development.

Technologies are an essential part of the development process of a compound. Smarter tools provide faster, more flexible and, ultimately, better-quality access to drug candidates. MorphoSys’s technologies are setting the standard for how antibodies will be made in the future. They provide rapid and direct access to fully human antibodies for use as research tools, diagnostics and therapeutics. 

Related Links